Antitumor activity of liposomal ErbB2/HER2 epitope peptide-based vaccine constructs incorporating TLR agonists and mannose receptor targeting.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biomaterials

• Publication date

  2011-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.biomaterials.2011.03.015PMID 21474175
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design of a Liposomal Candidate Vaccine Against Pseudomonas aeruginosa and its Evaluation in Triggering Systemic and Lung Mucosal Immunity

  2009cited by this paper
• Rational design and immunogenicity of liposome-based diepitope constructs: application to synthetic oligosaccharides mimicking the Shigella flexneri 2a O-antigen.

  2009cited by this paper
• Toll-like receptors and cancer

  2009cited by this paper
• Solid phase peptide synthesis of lipopeptide vaccines eliciting epitope-specific B-, T-helper and T-killer cell response.

  2009cited by this paper
• Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes.

  2008cited by this paper
• Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond.

  2008cited by this paper
• Dendritic cells in vivo: a key target for a new vaccine science.

  2008cited by this paper
• Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells

  2006cited by this paper
• Liposome-based Systems for Anti-tumor Vaccination: Influence of Lipopeptide Adjuvants

  2006cited by this paper
• Induction of effective and antigen-specific antitumour immunity by a liposomal ErbB2/HER2 peptide-based vaccination construct

  2005cited by this paper
• The mannose receptor: linking homeostasis and immunity through sugar recognition.

  2005cited by this paper
• Domain Exchange between Human Toll-like Receptors 1 and 6 Reveals a Region Required for Lipopeptide Discrimination*

  2005cited by this paper
• Liposomes as delivery systems in the prevention and treatment of infectious diseases

  2005cited by this paper
• Vaccination of Cytotoxic T Lymphocyte-Directed Peptides Elicited and Spread Humoral and Th1-Type Immune Responses to Prostate-Specific Antigen Protein in a Prostate Cancer Patient

  2005cited by this paper
• Mannose receptor-targeted vaccines

  2004cited by this paper
• Humoral Epitope-Spreading Following Immunization with a HER-2/neu Peptide Based Vaccine in Cancer Patients

  2004cited by this paper
• Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes.

  2004cited by this paper
• Relationship between Structures and Biological Activities of Mycoplasmal Diacylated Lipopeptides and Their Recognition by Toll-Like Receptors 2 and 6

  2004cited by this paper
• A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses.

  2004cited by this paper
• Liposomal delivery of antigen to human dendritic cells.

  2003cited by this paper
• Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer.

  2003cited by this paper
• Mini‐review: Regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross‐priming and direct priming?

  2003cited by this paper
• What's new in the field of cancer vaccines?

  2003cited by this paper
• Synthesis of an amphiphilic tetraantennary mannosyl conjugate and incorporation into liposome carriers.

  2003cited by this paper
• Recognition of lipopeptides by Toll-like receptors

  2002cited by this paper
• Microbial Lipopeptides Stimulate Dendritic Cell Maturation Via Toll-Like Receptor 21

  2001cited by this paper
• Design of highly immunogenic liposomal constructs combining structurally independent B cell and T helper cell peptide epitopes

  1999cited by this paper
• Systemic treatment with a recombinant erbB-2 receptor-specific tumor toxin efficiently reduces pulmonary metastases in mice injected with genetically modified carcinoma cells.

  1998cited by this paper
• Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngeneic hosts.

  1997cited by this paper
• Synthetic lipopeptides incorporated in liposomes: in vitro stimulation of the proliferation of murine splenocytes and in vivo induction of an immune response against a peptide antigen.

  1997cited by this paper
• Isolation, Structure Elucidation, and Synthesis of a Macrophage Stimulatory Lipopeptide from Mycoplasma fermentans Acting at Picomolar Concentration

  1997cited by this paper
• Cancer vaccines based on the identification of genes encoding cancer regression antigens.

  1997cited by this paper
• Liposomes as Carriers of Peptide Antigens: Induction of Antibodies and Cytotoxic T Lymphocytes to Conjugated and Unconjugated Peptides

  1995cited by this paper
• Human tumour antigens recognized by T-cells: perspectives for new cancer vaccines.

  1995cited by this paper
• Synthetic S‐(2,3‐dihydroxypropyl)‐cysteinyl peptides derived from the N‐terminus of the cytochrome subunit of the photoreaction centre of Rhodopseudomonas viridis enhance murine splenocyte proliferation

  1995cited by this paper
• Lipopolysaccharide-induced change of ADP-ribosylation of a cytosolic protein in bone-marrow-derived macrophages.

  1994cited by this paper
• Cytotoxic T lymphocytes induced by liposomal antigens: mechanisms of immunological presentation.

  1994cited by this paper
• Lipopeptide derivatives of bacterial lipoprotein constitute potent immune adjuvants combined with or covalently coupled to antigen or hapten.

  1989cited by this paper
• Colorimetric determination of neutral sugars by a resorcinol sulfuric acid micromethod.

  1988cited by this paper
• Lipopeptides of the N-terminus of Escherichia coli lipoprotein: synthesis, mitogenicity and properties in monolayer experiments.

  1987cited by this paper
• A murine renal cell carcinoma.

  1973cited by this paper

• Carbohydrate-Lectin Interactions Reprogram Dendritic Cells to Promote Type 1 Anti-Tumor Immunity.

  2024cites this paper
• Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective

  2024cites this paper
• Glycoconjugate Vaccines: Platforms and Adjuvants for Directed Immunity.

  2024cites this paper
• Immunogenicity of Recombinant Lipid-Based Nanoparticle Vaccines: Danger Signal vs. Helping Hand

  2023cites this paper
• Polymeric nanoparticles for DNA vaccine-based cancer immunotherapy: a review

  2023cites this paper
• Incorporation of a Toll-like receptor 2/6 agonist potentiates mRNA vaccines against cancer and infectious diseases

  2023cites this paper
• Lipid-Based Delivery Systems in Development of Genetic and Subunit Vaccines

  2022cites this paper
• Functionalized Nanoparticles Targeting Tumor-Associated Macrophages as Cancer Therapy

  2021cites this paper
• Preclinical models and technologies to advance nanovaccine development.

  2021cites this paper
• Mimicking Pathogens to Augment the Potency of Liposomal Cancer Vaccines

  2021cites this paper
• Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy

  2020cites this paper
• CMAR_A_232708 397..409

  2020cites this paper
• Research Progress Evaluating the Function and Mechanism of Anti-Tumor Peptides

  2020cites this paper
• Engineering Targeting Materials for Therapeutic Cancer Vaccines

  2020cites this paper
• Liposomes as tunable platform to decipher the antitumor immune response triggered by TLR and NLR agonists.

  2020cites this paper
• Boosting the Theranostic Effect of Liposomal Probes toward Prominin-1 through Optimized Dual-Site Targeting.

  2019cites this paper
• Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer.

  2019cites this paper
• Optimization of peptide-based cancer vaccine compositions, by sequential screening, using versatile liposomal platform.

  2019influential citation
• Liposome and immune system interplay: Challenges and potentials.

  2019cites this paper
• Distinct features of dendritic cell-based immunotherapy as cancer vaccines

  2018cites this paper
• Preclinical evaluation of mRNA trimannosylated lipopolyplexes as therapeutic cancer vaccines targeting dendritic cells

  2018cites this paper
• Peptide-based vaccines

  2018cites this paper
• Tailoring nanostructured lipid carriers for the delivery of protein antigens: Physicochemical properties versus immunogenicity studies.

  2017cites this paper
• Novel Adjuvant Based on the Pore-Forming Protein Sticholysin II Encapsulated into Liposomes Effectively Enhances the Antigen-Specific CTL-Mediated Immune Response

  2017cites this paper
• Enhancing tumor specific immune responses by transcutaneous vaccination

  2017cites this paper
• Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.

  2017cites this paper
• Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccines

  2017cites this paper
• A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice

  2017cites this paper
• Développement d'une stratégie de vaccination thérapeutique antitumorale basée sur l'utilisation de lipopolyplexes à ARN ciblant les cellules dendritiques

  2017cites this paper
• Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses.

  2017cites this paper
• Application Potential of Engineered Liposomes in Tumor Targeting

  2017cites this paper
• Development of C5AR-Targeted Nanoparticles for Delivery of Vaccines

  2017cites this paper
• A new strategy to prepare giant vesicles from surface active ionic liquids (SAILs): a study of protein dynamics in a crowded environment using a fluorescence correlation spectroscopic technique.

  2016cites this paper
• Liposomal constructs for antitumoral vaccination by the nasal route.

  2016cites this paper
• Chapter 7 – Targeting and imaging of cancer cells using nanomaterials

  2016cites this paper
• Modulation of Dendritic Cells by Nanotechnology-Based Immunotherapeutic Strategies.

  2016cites this paper
• Designing liposomal adjuvants for the next generation of vaccines.

  2016cites this paper
• Anti-tumor immunity induced by a novel nanoparticulate vaccine : a mechanistic approach

  2016cites this paper
• Peptide-Mediated Nanoparticle Drug Delivery System

  2016cites this paper
• Enhanced non-inflammasome mediated immune responses by mannosylated zwitterionic-based cationic liposomes for HIV DNA vaccines.

  2016cites this paper
• Dendritic cell targeted vaccines: Recent progresses and challenges

  2016cites this paper
• The Use of Synthetic Carriers in Malaria Vaccine Design

  2015cites this paper
• Dendritic Cell Targeting Vaccines

  2015cites this paper
• Nanoparticle-Mediated Delivery of Therapeutic Drugs

  2015cites this paper
• MPLA incorporation into DC-targeting glycoliposomes favours anti-tumour T cell responses.

  2015cites this paper
• Convergent chemo-enzymatic synthesis of mannosylated glycopeptides; targeting of putative vaccine candidates to antigen presenting cells

  2015cites this paper
• Carbohydrate Nanotechnology and its Applications for the Treatment of Cancer

  2015cites this paper
• Translational Peptide-associated Nanosystems: Promising Role as Cancer Vaccines.

  2015cites this paper
• Targeting myeloid cells using nanoparticles to improve cancer immunotherapy.

  2015cites this paper
• Multivalent nanomaterials: learning from vaccines and progressing to antigen-specific immunotherapies.

  2015cites this paper
• Airway administration of a highly versatile peptide-based liposomal construct for local and distant antitumoral vaccination.

  2015cites this paper
• Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines

  2015cites this paper
• Therapeutic antibodies in breast cancer.

  2014cites this paper
• Dendritic cell immunotherapy: clinical outcomes

  2014cites this paper
• Conception de constructions liposomiques destinées à la vaccination antitumorale par voie respiratoire

  2014influential citation
• Targeting human dendritic cells in situ to improve vaccines.

  2014cites this paper
• Recent progress in adjuvant discovery for peptide-based subunit vaccines

  2014cites this paper
• A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity.

  2014cites this paper
• Estudio de la capacidad adyuvante de la proteína Omp19 de Brucella spp. sobre la respuesta inmune adaptativa

  2014influential citation
• Liposomes as vaccine delivery systems: a review of the recent advances

  2014cites this paper
• Designing Liposomes as Vaccine Adjuvants

  2013cites this paper
• Dendritic cell-based nanovaccines for cancer immunotherapy.

  2013cites this paper
• Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting

  2013cites this paper
• Targeting Antigens to Dendritic Cell Receptors for Vaccine Development

  2013cites this paper
• Targeting dendritic cells--why bother?

  2013cites this paper
• VLPs and particle strategies for cancer vaccines

  2013cites this paper
• Perspectives Targeting dendritic cells — why bother ?

  2013cites this paper
• Mucosal immunity and the onset of allergic disease.

  2013cites this paper
• Induction of robust immunity by the emulsification of recombinant lipidated dengue-1 envelope protein domain III.

  2013cites this paper
• Cancer Vaccination, Will You Have To Pay The Toll?

  2013cites this paper
• Prospects of combinatorial synthetic peptide vaccine-based immunotherapy against cancer.

  2013cites this paper
• Multilayer nanoparticles for sustained delivery of exenatide to treat type 2 diabetes mellitus.

  2013cites this paper
• Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice

  2012cites this paper
• Targeting nanoparticles to dendritic cells for immunotherapy.

  2012influential citation
• Liposomes and Other Nanoparticles as Cancer Vaccines and Immunotherapeutics

  2012cites this paper
• Liposome-based delivery system for vaccine candidates: constructing an effective formulation.

  2012cites this paper
• TLR Agonists as Vaccine Adjuvants

  2012cites this paper
• Innovation in Vaccinology

  2012cites this paper
• Use of lectin-functionalized particles for oral immunotherapy.

  2012cites this paper
• Nanoimmunotherapy: application of nanotechnology for sustained and targeted delivery of antigens to dendritic cells.

  2012cites this paper
• Novel glycolipid TLR2 ligands of the type Pam2Cys-α-Gal: synthesis and biological properties.

  2012cites this paper
• Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells.

  2012cites this paper
• Multi-core vesicle nanoparticles based on vesicle fusion for delivery of chemotherapic drugs.

  2011cites this paper